Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-01-12T11:14:48.795Z Has data issue: false hasContentIssue false
  • English
  • Français

A Beta Adrenergic Stimulant (Salbutamol) versus Clomipramine in Depression: A Controlled Study

Published online by Cambridge University Press:  29 January 2018

Y. Lecrubier ,
A. J. Puech ,
R. Jouvent ,
P. Simon  and
D. Widlocher
Y. Lecrubier
Affiliation:
Département de Psychiatrie Adulte, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France
A. J. Puech
Affiliation:
Departement de Pharmacologie Clinique, Hôpital de la Pitié Salpêtrière, 91 Boulevard de l'Hôpital, 75013, Paris, France
R. Jouvent
Affiliation:
Département de Psychiatrie Adulte, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France
P. Simon
Affiliation:
Departement de Pharmacologie Clinique, Hôpital de la Pitié Salpêtrière, 91 Boulevard de l'Hôpital, 75013, Paris, France
D. Widlocher
Affiliation:
Département de Psychiatrie Adulte, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France
Get access Rights & Permissions [Opens in a new window]

Summary

A controlled study comparing salbutamol (6 mg/day) to clomipramine (150 mg/day), both given by intravenous infusion, was performed on depressed inpatients (10 per group). The symptomatology was evaluated by two blind observers at days 0, 5 and 15 using the Hamilton Rating Scale. Both treatments were effective on the overall symptomatology but the onset of action of salbutamol was more rapid.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 136 , Issue 4 , April 1980 , pp. 354 - 358
Copyright
Copyright © Royal College of Psychiatrists, 1980 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.CrossRefGoogle ScholarPubMed
Frances, G., Puech, A. J. & Simon, P. (1978) Profil psychopharmacologique de l'isoprénaline et du salbutamol. Journal de Pharmacologie, Paris, 9, 25–34.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–96.Google Scholar
Lecrubier, Y., Jouvent, R., Puech, A., Simon, P. & Widlocher, D. (1977) Effet antidépresseur d'un stimulant béta adrénergique. Nouvelle Presse Médicale, 6, 2786.Google Scholar
Schubert, D. S. P. A bi-phasic change in mood with a tricyclic antidepressant. Journal of Nervous and Mental Disease. In press.Google Scholar
Simon, P., Lecrubier, Y., Jouvent, R., Puech, A. J., Allilaire, J. F. & Widlocher, D. (1978) Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant. Psychological Medicine, 8, 335–8.Google Scholar
Taves, D. R. (1974) Minimization: a new method of assigning patients to treatment and control groups. Clinical Pharmacology and Therapeutics, 15, 443–53.Google Scholar
Widlocher, D., Lecrubier, Y., Jouvent, R., Puech, A. J. & Simon, P. (1977) Antidepressant effect of salbutamol. Lancet, ii, 767–8.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.